Elanco Animal Health (ELAN) Accounts Payables (2017 - 2026)

Elanco Animal Health has disclosed Accounts Payables across 10 years of filings, most recently posting $372.0 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $372.0 million, up 12.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $372.0 million (up 12.73% YoY), and the FY2025 annual result was $368.0 million, up 24.32% from the prior year.
• Accounts Payables came in at $372.0 million for Q1 2026 at Elanco Animal Health, up from $368.0 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $402.0 million in Q1 2022 to a low of $259.0 million in Q3 2024.
• The 5-year median for Accounts Payables is $352.0 million (2025), against an average of $339.2 million.
• Across the five-year window, Accounts Payables sank 30.77% in 2023 and jumped 35.91% in 2025, its largest moves.
• Elanco Animal Health's Accounts Payables stood at $390.0 million in 2022, then tumbled by 30.77% to $270.0 million in 2023, then grew by 9.63% to $296.0 million in 2024, then climbed by 24.32% to $368.0 million in 2025, then grew by 1.09% to $372.0 million in 2026.
• The last three Accounts Payables figures came in at $372.0 million (Q1 2026), $368.0 million (Q4 2025), and $352.0 million (Q3 2025), per Business Quant data.